Antibody developability assessment stands as a pivotal process in biopharmaceutical development, offering crucial insights into the feasibility and potential success of antibody-based therapeutics. This comprehensive evaluation encompasses a range of factors, including structural integrity, stability, manufacturability, and immunogenicity, aiming to identify and mitigate potential challenges...